Renaissance Technologies
ASXC

Renaissance Technologies’s Asensus Surgical, Inc. ASXC Stock Holding History

Renaissance Technologies’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-54,400
Closed -$27K – 4220
2023
Q2 		$27K Sell
54,400
-75,573
-58% -$45.2K ﹤0.01% 3726
2023
Q1 		$86K Sell
129,973
-22,500
-15% -$15.2K ﹤0.01% 3532
2022
Q4 		$53K Buy
152,473
+56,300
+59% +$22.9K ﹤0.01% 3787
2022
Q3 		$43K Sell
96,173
-234,891
-71% -$122K ﹤0.01% 3794
2022
Q2 		$132K Sell
331,064
-1,057,138
-76% -$472K ﹤0.01% 3773
2022
Q1 		$870K Sell
1,388,202
-394,659
-22% -$304K ﹤0.01% 2821
2021
Q4 		$1.98M Buy
+1,782,861
New +$2.75M ﹤0.01% 2158
2021
Q2 		– Sell
-2,700,348
Closed -$8.78M – 3852
2021
Q1 		$8.78M Buy
2,700,348
+1,273,348
+89% +$4.61M 0.01% 1283
2020
Q4 		$892K Sell
1,427,000
-505,458
-26% -$231K ﹤0.01% 2557
2020
Q3 		$671K Buy
1,932,458
+1,613,991
+507% +$625K ﹤0.01% 2706
2020
Q2 		$172K Buy
+318,467
New +$154K ﹤0.01% 3192
2020
Q1 		– Sell
-53,956
Closed -$79K – 3892
2019
Q4 		$79K Buy
+53,956
New +$187K ﹤0.01% 3345
2016
Q2 		– Sell
-2,408
Closed -$133K – 3551
2016
Q1 		$133K Buy
+2,408
New +$103K ﹤0.01% 3169
2015
Q3 		– Sell
-4,715
Closed -$184K – 3414
2015
Q2 		$184K Buy
4,715
+1,784
+61% +$82.2K ﹤0.01% 2998
2015
Q1 		$112K Buy
+2,931
New +$111K ﹤0.01% 2997
2014
Q4 		– Sell
-3,515
Closed -$199K – 3160
2014
Q3 		$199K Sell
3,515
-3,962
-53% -$214K ﹤0.01% 2554
2014
Q2 		$490K Buy
+7,477
New +$432K ﹤0.01% 2330

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Renaissance Technologies's ASXC Position: Q3 2023 in Review

Renaissance Technologies sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 54,400 shares — an estimated $27K sold.

Renaissance Technologies first reported a position in ASXC in Q2 2014 and held it in 17 quarters. The position peaked at $8.78M in Q1 2021. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Renaissance Technologies reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 54,400 Asensus Surgical, Inc. shares in Q3 2023, an estimated $27K.
  • Renaissance Technologies first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 17 quarters.
  • Renaissance Technologies's Asensus Surgical, Inc. position peaked at $8.78M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.